Table 2.

Association of CD169⁺CD8⁺ T cells density with clinicopathologic characteristics.

		CD169+CD8+ T cells in PLN			CD169+CD8+ T cells in DLN
		No. of patients (%)			No. of patients (%)
Variables	Low	High				p	Low	High	p
Age, y			0.63			0.012
≤ 58	24	23		29	18
> 58	24	28		19	33
Gender			0.13			0.477
Male	19	28		21	26
Female	29	23		27	25
Tumor (T) stage			0.002			< .0001
pTis + pT1 + pT2 + pT3	13	30		10	33
pT4	35	21		38	18
Nodal (N) status			0.002			< .0001
Negative	7	22		2	27
Positive	41	29		46	24
Distant metastases (M)			< .0001			< .0001
Negative	21	43		21	43
Positive	27	8		27	8
Dukes' stage			0.001			< .0001
A + B	7	22		2	27
C + D	41	29		46	24
Differentiation			0.605			0.058
Low	14	12		17	9
High + Moderate	34	39		31	42
No. of lymph nodes analyzed			0.584			0.341
≤ 12	19	23		18	24
> 12	29	28		30	27
Location			0.485			0.622
Colon	26	24		23	27
Rectal	22	27		25	24
Mucinous (colloid) adenocarcinoma			0.305			0.305
Yes	47	51		47	51
No	1	0		1	0

Abbreviations: PLN, peri-tumor lymph node; DLN, distant-tumor lymph node.